| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/30/2001 | US6309841 Expression vector for the generation of stable genetically engineered polypeptides |
| 10/30/2001 | US6309838 Monitoring nucleotide sequences for damage; incubate sample with proteins associated with nucleotide sequence breaks, label protein and monitor sample for signal |
| 10/30/2001 | US6309834 Detecting homogeneity in nucleotide sequences; generate clones in cells, generate ribonucleic acids, amplify and resolve nucleotide sequences, clone preferential sequences into plasmid, determine sequence of preferential clones |
| 10/30/2001 | US6309832 Screening for flea allergy dermatitis; immobilize flea allergen, incubate with immunoglobulin, remove unbound particles, screen sample for immunoglobulin complex formation |
| 10/30/2001 | US6309831 Method of manufacturing biological chips |
| 10/30/2001 | US6309830 Nucleotide sequence which encodes a synthetic transfer ribonucleic acid; for use as a tool in gene therapy |
| 10/30/2001 | US6309829 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 10/30/2001 | US6309827 Detecting genomic marker and extracellular particles; recover sample, obtain genomic marker from the solid support, detect preferential particles and genomic markers |
| 10/30/2001 | US6309826 Diagnosing tumors; monitor tumorous tissue for nucleotide sequences coding tumor glycoprotein, compare to amount of nucleotide sequences coding tumor glycoprotein in healthy sample, classify cells |
| 10/30/2001 | US6309821 DNA encoding a PAC10 human homolog |
| 10/30/2001 | US6309820 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 10/30/2001 | US6309817 Identifying substances that repress or prevent or attenuate virulence gene expression in an infectious microorganism and phenotypically convert it to a non-pathogen; simplification, accuracy |
| 10/30/2001 | US6309651 A method of inhibiting, moderating or diagnosing pseudomonas aeruginosa infection is disclosed. |
| 10/30/2001 | US6309649 The fusion (f) protein, attachment (g) protein and matrix (m) protein of respiratory syncytial virus (rsv) are isolated and purified. |
| 10/30/2001 | US6309648 Induces formation of protective antibodies against an infection by a bacteria selected from the group consisting of b. pertussis, b. parapertussis, and b. bronchiseptica when administered to a human or animal host. |
| 10/30/2001 | US6309647 The recombinant viruses and gene products therefrom are useful for eliciting protection against canine distemper virus and/or measles virus. |
| 10/30/2001 | US6309645 A method of suppressing an immune response in a mammal. |
| 10/30/2001 | US6309644 Parasitic nematode transglutaminase proteins and uses thereof |
| 10/30/2001 | US6309643 Diagnosis and treatment of inflammatory bowel disease using microbial antigens. |
| 10/30/2001 | US6309641 Which can be used immunologically as a vaccine for leptospirosis caused by this organism. |
| 10/30/2001 | US6309638 Netrins |
| 10/30/2001 | US6309637 For treating or preventing disorders associated with expression of mag4v. |
| 10/30/2001 | US6309634 Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV) |
| 10/30/2001 | US6308458 Herbicide-tolerant plants and methods of controlling the growth of undesired vegetation |
| 10/30/2001 | CA2227308C Dna sequence coding for a polypeptide which enhances virus infection of host insects |
| 10/30/2001 | CA2226889C An expression control sequence for general and effective expression of genes in plants |
| 10/30/2001 | CA2220045C Method for the specific coupling of the cap of the extremity 5' of a fragment mrna and preparation of mrna and complete cdna |
| 10/30/2001 | CA2214579C Subtilisin dy variants having decreased adsorption and increased hydrolysis |
| 10/30/2001 | CA2214395C Proteinase k variants having decreased adsorption and increased hydrolysis |
| 10/30/2001 | CA2214348C Subtilisin carlsberg variants having decreased adsorption and increased hydrolysis |
| 10/30/2001 | CA2170491C Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
| 10/30/2001 | CA2170143C Cell death regulator |
| 10/30/2001 | CA2093643C Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 10/30/2001 | CA2070826C Fermentation process for the production of pyrimidine deoxyribonucleosides |
| 10/30/2001 | CA2047843C Method and product for the treatment of gastric disease |
| 10/30/2001 | CA2032153C Application of new dna fragments as sequence coding for a signal peptide for the secretion of mature proteins by recombinant yeasts, expression cassettes, processed yeasts and corresponding protein preparation process. |
| 10/30/2001 | CA2030073C Enantioselective amidases, dna sequences encoding them, method of pre paration, and utilization |
| 10/30/2001 | CA2002833C Interferon-gamma binding proteins |
| 10/30/2001 | CA1341311C Transduced fibroblasts and uses therefor |
| 10/26/2001 | CA2319149A1 Medicament for treatment of duchenne muscular dystrophy |
| 10/26/2001 | CA2304991A1 Synthetic gene of bovine viral diarrhoea virus |
| 10/25/2001 | WO2001080152A1 Life science simulation method and life science simulator |
| 10/25/2001 | WO2001079857A2 System and method for treatment of samples on solid supports |
| 10/25/2001 | WO2001079855A2 Method for quantification of akt protein expression |
| 10/25/2001 | WO2001079850A2 Method and apparatus for selective biological material detection |
| 10/25/2001 | WO2001079845A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 10/25/2001 | WO2001079563A2 Degradable nucleic acid probes and nucleic acid detection methods |
| 10/25/2001 | WO2001079560A2 Medicine response assay in respiratory disease |
| 10/25/2001 | WO2001079559A1 System to detect protein-protein interactions |
| 10/25/2001 | WO2001079558A1 High-throughput screening of expressed dna libraries in filamentous fungi |
| 10/25/2001 | WO2001079556A2 Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers |
| 10/25/2001 | WO2001079553A1 Method and compositions for ordering restriction fragments |
| 10/25/2001 | WO2001079550A2 Genetic testing for determining the risk of pouchitis development |
| 10/25/2001 | WO2001079549A2 CONSTRUCTION OF UNI-DIRECTIONALLY CLONED cDNA LIBRARIES FROM MESSENGER RNA FOR IMPROVED 3'END DNA SEQUENCING |
| 10/25/2001 | WO2001079548A2 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction |
| 10/25/2001 | WO2001079544A1 Method for attaching oligonucleotide to solid support and the oligonucleotide array prepared by the method thereof |
| 10/25/2001 | WO2001079540A2 Methods for measuring drug resistance |
| 10/25/2001 | WO2001079539A2 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep |
| 10/25/2001 | WO2001079538A2 Cell-binding nucleic acid molecules (aptamers) |
| 10/25/2001 | WO2001079534A1 A method of detecting neoplastic or non-neoplastic cells |
| 10/25/2001 | WO2001079526A2 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 10/25/2001 | WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 10/25/2001 | WO2001079524A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 10/25/2001 | WO2001079520A1 Hybrid glycosylated products and their production and use |
| 10/25/2001 | WO2001079518A2 Codon optimisation for expression in retrovirus packaging cells |
| 10/25/2001 | WO2001079517A2 Control of fruit dehiscence in arabidopsis by indehiscent1 genes |
| 10/25/2001 | WO2001079516A2 Maize cellulose synthases and uses thereof |
| 10/25/2001 | WO2001079515A2 Methods of identifying transgenic plants using morphological markers |
| 10/25/2001 | WO2001079514A2 Amino acid:glyoxylate aminotransferase genes from plants and uses thereof |
| 10/25/2001 | WO2001079513A2 Process for modifying plants |
| 10/25/2001 | WO2001079512A2 Vector and method for targeted replacement and disruption of an integrated dna sequence |
| 10/25/2001 | WO2001079510A1 Materials and methods relating to immune responses to fusion proteins |
| 10/25/2001 | WO2001079509A1 Human metalloprotease and polynucleotides encoding the same |
| 10/25/2001 | WO2001079508A1 A novel polypeptide, a human mitochondrial carrier protein 9 and the polynucleotide encoding the polypeptide |
| 10/25/2001 | WO2001079507A2 EXPRESSION-REGULATING SEQUENCES AND EXPRESSION PRODUCTS IN THE FIELD OF FILAMENTOUS FUNGI $i(CHRYSOSPORIUM) |
| 10/25/2001 | WO2001079506A2 Treatment of ocular neovascularization and related diseases |
| 10/25/2001 | WO2001079505A2 INHIBITION OF BONE TUMOR FORMATION USING ANTISENSE cDNA THERAPY |
| 10/25/2001 | WO2001079504A1 23155 NOVEL PROTEIN HUMAN 5-α REDUCTASES AND USES THEREFOR |
| 10/25/2001 | WO2001079503A1 L-glutamate oxidase |
| 10/25/2001 | WO2001079502A2 Vectors for gene therapy |
| 10/25/2001 | WO2001079501A2 Nucleic acid coding for at least one raf partial sequence with a mekk1 binding site |
| 10/25/2001 | WO2001079500A2 Streptococcus thermopilus operons involved in exopolysaccharide (eps) synthesis |
| 10/25/2001 | WO2001079499A1 Method of modifying the content of cottonseed oil |
| 10/25/2001 | WO2001079498A2 16051a and 16051b, novel human pdz family members and uses thereof |
| 10/25/2001 | WO2001079497A2 33556, a human transporter and uses thereof |
| 10/25/2001 | WO2001079496A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 10/25/2001 | WO2001079495A1 Method of inducing tumor cell apoptosis using trail/apo-2 ligand gene transfer |
| 10/25/2001 | WO2001079494A1 Agonist antibodies |
| 10/25/2001 | WO2001079493A1 New lipid binding protein 2 |
| 10/25/2001 | WO2001079492A2 Lipid binding protein 3 |
| 10/25/2001 | WO2001079491A1 A novel polypeptide-human chloride channel protein 12 and the polynucleotide encoding said polypeptide |
| 10/25/2001 | WO2001079490A1 A novel polypeptide- prostate specific membrane antigen 16 and the polynucleotide encoding said polypeptide |
| 10/25/2001 | WO2001079489A2 39228, a human alcohol dehydrogenase and uses therefor |
| 10/25/2001 | WO2001079488A2 14257,protein kinase molecules and uses therefor |
| 10/25/2001 | WO2001079487A2 Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene |
| 10/25/2001 | WO2001079486A2 Method and apparatus for plasmid recovery involving ultrafiltration |
| 10/25/2001 | WO2001079485A2 Direct isolation of transposon insertions tagging transcribed portions of genes |
| 10/25/2001 | WO2001079481A2 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 10/25/2001 | WO2001079480A1 Albumin fusion proteins |
| 10/25/2001 | WO2001079479A2 Methods for selective targeting |